Company Filing History:
Years Active: 2018
Title: Maike Veyhl-Wichmann: Innovator in Glucose Regulation
Introduction
Maike Veyhl-Wichmann is a notable inventor based in Würzburg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the area of glucose regulation. Her innovative work focuses on developing peptides that can enhance insulin sensitivity and regulate glucose absorption.
Latest Patents
Maike Veyhl-Wichmann holds a patent for her invention titled "Peptides derived from RS1 which down-regulate glucose absorption after a glucose-rich meal and increase insulin sensitivity." This patent describes a pharmaceutical composition that includes a (poly)peptide derived from QEP or its derivatives. The composition is intended for use in preventing or treating diseases associated with glucose and galactose uptake. It also includes methods for screening compounds that can modulate glucose absorption and predict patient responses to treatment.
Career Highlights
Maike Veyhl-Wichmann is affiliated with Julius-Maximilians-Universität Würzburg, where she conducts her research and development work. Her innovative approach to addressing metabolic disorders has garnered attention in the scientific community. She has successfully translated her research into practical applications that can benefit patients suffering from glucose-related disorders.
Collaborations
Maike collaborates with esteemed colleagues, including Alexandra Friedrich and Jürgen Groll. These partnerships enhance her research efforts and contribute to the advancement of knowledge in her field.
Conclusion
Maike Veyhl-Wichmann's contributions to the field of glucose regulation through her innovative peptides represent a significant advancement in pharmaceutical science. Her work has the potential to improve the lives of many individuals affected by metabolic disorders.